Procter & Gamble Health Limited (NSE:PGHL)
India · Delayed Price · Currency is INR 5,220.00
+121.00 (2.37%)
May 13, 2026, 3:29 PM IST
Procter & Gamble Health Market Cap
Procter & Gamble Health has a market cap or net worth of 84.71 billion as of May 13, 2026. Its market cap has decreased by -1.19% in one year.
Market Cap
84.71B
Enterprise Value
81.91B
Revenue
13.49B
Ranking
n/a
PE Ratio
28.86
Stock Price
5,220.00
Market Cap Chart
Since June 14, 1999, Procter & Gamble Health's market cap has increased from 9.75B to 84.71B, an increase of 769.15%. That is a compound annual growth rate of 8.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 84.71B | -10.49% |
| Dec 31, 2025 | 94.63B | 8.85% |
| Dec 31, 2024 | 86.94B | 5.90% |
| Dec 29, 2023 | 82.10B | 23.12% |
| Dec 30, 2022 | 66.69B | -24.14% |
| Dec 31, 2021 | 87.91B | -22.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eris Lifesciences | 192.03B |
| Cohance Lifesciences | 186.77B |
| Alembic Pharmaceuticals | 154.71B |
| Alivus Life Sciences | 137.62B |
| Strides Pharma Science | 106.63B |
| Akums Drugs and Pharmaceuticals | 85.29B |
| Sudeep Pharma | 74.32B |
| Aarti Pharmalabs | 69.46B |